Literature DB >> 11343485

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

A S Go1, E M Hylek, K A Phillips, Y Chang, L E Henault, J V Selby, D E Singer.   

Abstract

CONTEXT: Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described.
OBJECTIVE: To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050. DESIGN, SETTING, AND PATIENTS: Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997. MAIN OUTCOME MEASURES: Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050.
RESULTS: A total of 17 974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older.
CONCLUSIONS: Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.

Entities:  

Mesh:

Year:  2001        PMID: 11343485     DOI: 10.1001/jama.285.18.2370

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  1706 in total

1.  MEDEX South Carolina: a progress report.

Authors:  K J Buhmeyer; A R Hutson
Journal:  J S C Med Assoc       Date:  1975-11

2.  Short report: managing anticoagulation. Comparison of results at three primary care centres.

Authors:  Ross E G Upshur; Christine Papoushek; Denis Macdonald; Guilherme Dantas
Journal:  Can Fam Physician       Date:  2003-02       Impact factor: 3.275

3.  Outcomes of patients with periprocedural atrial fibrillation undergoing percutaneous coronary intervention for chronic total occlusion.

Authors:  Barbara E Stähli; Cathérine Gebhard; Michael Gick; Kambis Mashayekhi; Miroslaw Ferenc; Heinz Joachim Buettner; Franz-Josef Neumann; Aurel Toma
Journal:  Clin Res Cardiol       Date:  2017-08-03       Impact factor: 5.460

4.  [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

Authors:  B Leithäuser; F Kasch; T Broemel; J-W Park
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

Review 5.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

6.  Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Authors:  Renate B Schnabel; Thor Aspelund; Guo Li; Lisa M Sullivan; Astrid Suchy-Dicey; Tamara B Harris; Michael J Pencina; Ralph B D'Agostino; Daniel Levy; William B Kannel; Thomas J Wang; Richard A Kronmal; Philip A Wolf; Gregory L Burke; Lenore J Launer; Ramachandran S Vasan; Bruce M Psaty; Emelia J Benjamin; Vilmundur Gudnason; Susan R Heckbert
Journal:  Arch Intern Med       Date:  2010-11-22

7.  Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.

Authors:  Margaret C Fang; Praveen Panguluri; Edward L Machtinger; Dean Schillinger
Journal:  Patient Educ Couns       Date:  2009-01-25

8.  Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL).

Authors:  Gerald S Bloomfield; Tecla M Temu; Constantine O Akwanalo; Peng-Sheng Chen; Wilfred Emonyi; Susan R Heckbert; Myra M Koech; Imran Manji; Changyu Shen; Matteo Vatta; Eric J Velazquez; Jennifer Wessel; Sylvester Kimaiyo; Thomas S Inui
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

9.  The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Authors:  Ming-Liang Zuo; Shasha Liu; Koon-Ho Chan; Kui-Kai Lau; Boon-Hor Chong; Kwok-Fai Lam; Yap-Hang Chan; Yuk-Fai Lau; Gregory Y H Lip; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  J Interv Card Electrophysiol       Date:  2013-02-07       Impact factor: 1.900

Review 10.  Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation.

Authors:  Robert M A van der Boon; Patrick Houthuizen; Rutger-Jan Nuis; Nicolas M van Mieghem; Frits Prinzen; Peter P T de Jaegere
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.